Last reviewed · How we verify
Non-narcotic group regimen
At a glance
| Generic name | Non-narcotic group regimen |
|---|---|
| Also known as | Ibuprofen 800mg every 8 hours, Acetaminophen 500Mg Tab x2 every 8 hours, ibuprofen + acetaminophen |
| Sponsor | MetroHealth Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial (PHASE4)
- Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial (PHASE4)
- Effect of Opioid Free Anesthetic on Post-Operative Opioid Consumption After Laparoscopic Bariatric Surgery (PHASE3)
- Influence of Patient Sex on Pain Control and Multimodal Analgesia in Total Knee Arthroplasty (NA)
- Chronic Non-Specific Neck Pain Treated With Tai Chi and Chiropractic Care (NA)
- A Novel Usage of Transdermal Scopolamine in Reducing Narcotic Usage in Outpatient Hand Surgery
- The Effect of Self-Forgiveness on Self-Stigma in Addiction. (NA)
- Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Non-narcotic group regimen CI brief — competitive landscape report
- Non-narcotic group regimen updates RSS · CI watch RSS
- MetroHealth Medical Center portfolio CI